The total European market for insulin pens comprises the prefilled pen segment, the pen cartridge segment, the pen needle segment and the safety pen needle segment. In 2015, the largest segment in the total insulin pen market was the prefilled pen segment, which represented over 80% of the total market value. Prefilled pens account for such a large portion of the market because they are highly preferred to reusable pens by diabetic patients. It is expected that this trend will continue over the forecast period, as reusable pens do not offer a financial incentive and essentially perform the same function as prefilled pens. Growth of the segment will be driven by unit sales growth and modest ASP appreciation of the overall insulin market.
Insulin pens are shaped like a writing pen, but have a reservoir for insulin and are used as a delivery method for insulin. To administer insulin, patients must remove the pen cap, clean the injection site with an alcohol swab, attach a pen needle, prime the pen, dial the appropriate dosage amount and finally inject the insulin. There is a dose dial on the side of the pen so the patient can choose the required dose.
Insulin pens are either prefilled or reusable with a disposable cartridge component, and generally carry 300 units of insulin. Most brands of insulin are available in pen format. This delivery method offers several advantages over the traditional vial and syringe delivery method. Pens offer ease-of-handling, improved accuracy, more discreet use and less injection pain.
'
TABLE OF CONTENTS I
LIST OF FIGURES IV
LIST OF CHARTS VI
EXECUTIVE SUMMARY 1
EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
MARKETS INCLUDED 9
KEY REPORT UPDATES 10
VERSION HISTORY 10
RESEARCH METHODOLOGY 11
1.1 RESEARCH SCOPE 11
1.2 IDATA’S 9-STEP METHODOLOGY 11
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 13
Step 3: Preparation for Interviews & Questionnaire Design 14
Step 4: Performing Primary Research 15
Step 5: Research Analysis: Establishing Baseline Estimates 17
Step 6: Market Forecast and Analysis 18
Step 7: Identify Strategic Opportunities 20
Step 8: Final Review and Market Release 21
Step 9: Customer Feedback and Market Monitoring 22
DISEASE OVERVIEW 23
2.1 INTRODUCTION 23
2.1.1 Types of Diabetes 23
2.1.2 Diabetes Complications 25
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 27
2.1.4 Signs and Symptoms 28
2.1.5 Diabetes Monitoring 29
2.1.6 Treatment 31
2.1.7 Drug Delivery Systems 33
COUNTRY PROFILES 35
3.1 INTRODUCTION 35
3.1.1.1 Population 35
3.1.1.2 GDP Per Capita 35
3.1.1.3 Units 35
3.2 GERMANY 36
3.3 FRANCE 37
3.4 UNITED KINGDOM 38
3.5 ITALY 39
3.6 SPAIN 40
3.7 BENELUX 41
3.8 SCANDINAVIA 42
3.9 AUSTRIA 43
3.10 SWITZERLAND 44
3.11 PORTUGAL 45
INSULIN PEN MARKET 46
4.1 INTRODUCTION 46
4.2 MARKET OVERVIEW 48
4.3 MARKET ANALYSIS AND FORECAST 53
4.3.1 Total Insulin Pen Market 53
4.3.2 Prefilled Insulin Pen Market 57
4.3.3 Insulin Pen Cartridge Market 65
4.3.4 Insulin Pen Needle Market 72
4.3.5 Safety Insulin Pen Needle Market 80
4.4 DRIVERS AND LIMITERS 88
4.4.1 Market Drivers 88
4.4.2 Market Limiters 89
4.5 COMPETITIVE MARKET SHARE ANALYSIS 91
ABBREVIATIONS 95
Chart 1 1: Diabetes Diagnosis, Treatment and Drug Delivery, Europe, 2012 – 2022 3
Chart 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Overview, Europe, 2012 & 2022 3
Chart 3 1: Country Profile, Germany, 2015 36
Chart 3 2: Country Profile, France, 2015 37
Chart 3 3: Country Profile, United Kingdom, 2015 38
Chart 3 4: Country Profile, Italy, 2015 39
Chart 3 5: Country Profile, Spain, 2015 40
Chart 3 6: Country Profile, Benelux, 2015 41
Chart 3 7: Country Profile, Scandinavia, 2015 42
Chart 3 8: Country Profile, Austria, 2015 43
Chart 3 9: Country Profile, Switzerland, 2015 44
Chart 3 10: Country Profile, Portugal, 2015 45
Chart 4 1: Total Insulin Pen Market by Segment, Europe, 2015 51
Chart 4 2: Total Insulin Pen Market Breakdown, Europe, 2015 52
Chart 4 3: Total Insulin Pen Market Breakdown, Europe, 2022 52
Chart 4 4: Total Insulin Pen Market, Europe, 2012 – 2022 54
Chart 4 5: Prefilled Insulin Pen Market, Europe, 2012 – 2022 (€M) 59
Chart 4 6: Insulin Pen Cartridge Market, Europe, 2012 – 2022 (€M) 66
Chart 4 7: Insulin Pen Needle Market, Europe, 2012 – 2022 (€M) 74
Chart 4 8: Safety Insulin Pen Needle Market, Europe, 2012 – 2022 (€M) 82
Chart 4 9: Leading Competitors, Insulin Pen Market, Europe, 2015 94
Figure 1 1: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2) 4
Figure 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, Europe, 2015 5
Figure 1 4: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (1 of 2) 6
Figure 1 5: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (2 of 2) 7
Figure 1 6: Recent Events in the Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2016 8
Figure 2 1: Major Types of Diabetes and Related Pathologies, Europe, 2015 24
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, Europe, 2015 28
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, Europe, 2015 29
Figure 4 1: Total Insulin Pen Market by Segment, Europe, 2012 – 2022 (€M) 49
Figure 4 2: Total Insulin Pen Market by Segment, Europe, 2012 – 2022 (US$M) 50
Figure 4 3: Total Insulin Pen Market, Europe, 2012 – 2022 (€ and US$) 53
Figure 4 4: Total Insulin Pen Market by Country, Europe, 2012-2022 (€M) 55
Figure 4 5: Total Insulin Pen Market by Country, Europe, 2012-2022 (US$M) 56
Figure 4 6: Prefilled Insulin Pen Market, Europe, 2012-2022 (€ and US$) 58
Figure 4 7: Units Sold (Millions) by Country, Prefilled Insulin Pen Market, Europe, 2012-2022 60
Figure 4 8: Average Sales Price by Country, Prefilled Insulin Pen Market, Europe, 2012-2022 (€) 61
Figure 4 9: Average Sales Price by Country, Prefilled Insulin Pen Market, Europe, 2012-2022 (US$) 62
Figure 4 10: Prefilled Insulin Pen Market by Country, Europe, 2012-2022 (€M) 63
Figure 4 11: Prefilled Insulin Pen Market by Country, Europe, 2012-2022 (US$M) 64
Figure 4 12: Insulin Pen Cartridge Market, Europe, 2012-2022 (€ and US$) 66
Figure 4 13: Units Sold (Millions) by Country, Insulin Pen Cartridge Market, Europe, 2012-2022 67
Figure 4 14: Average Sales Price by Country, Insulin Pen Cartridge Market, Europe, 2012-2022 (€) 68
Figure 4 15: Average Sales Price by Country, Insulin Pen Cartridge Market, Europe, 2012-2022 (US$) 69
Figure 4 16: Insulin Pen Cartridge Market by Country, Europe, 2012-2022 (€M) 70
Figure 4 17: Insulin Pen Cartridge Market by Country, Europe, 2012-2022 (US$M) 71
Figure 4 18: Insulin Pen Needle Market, Europe, 2012-2022 (€ and US$) 73
Figure 4 19: Units Sold (Millions) by Country, Insulin Pen Needle Market, Europe, 2012-2022 75
Figure 4 20: Average Sales Price by Country, Insulin Pen Needle Market, Europe, 2012-2022 (€) 76
Figure 4 21: Average Sales Price by Country, Insulin Pen Needle Market, Europe, 2012-2022 (US$) 77
Figure 4 22: Insulin Pen Needle Market by Country, Europe, 2012-2022 (€M) 78
Figure 4 23: Insulin Pen Needle Market by Country, Europe, 2012-2022 (US$M) 79
Figure 4 24: Safety Insulin Pen Needle Market, Europe, 2012-2022 (€ and US$) 81
Figure 4 25: Units Sold (Millions) by Country, Safety Insulin Pen Needle Market, Europe, 2012-2022 83
Figure 4 26: Average Sales Price by Country, Safety Insulin Pen Needle Market, Europe, 2012-2022 (€) 84
Figure 4 27: Average Sales Price by Country, Safety Insulin Pen Needle Market, Europe, 2012-2022 (US$) 85
Figure 4 28: Safety Insulin Pen Needle Market by Country, Europe, 2012-2022 (€M) 86
Figure 4 29: Safety Insulin Pen Needle Market by Country, Europe, 2012-2022 (US$M) 87
Figure 4 30: Drivers and Limiters, Insulin Pen Market, Europe, 2015 90
Figure 4 31: Leading Competitors, Insulin Pen Market, Europe, 2015 93
Novo Nordisk
Sanofi
Roche
Johnson & Johnson
Eli Lilly
Abbott
Ascensia
Becton Dickinson
Medtronic
Menarini
DexCom
Ypsomed
Insulet
Artsana
B. Braun
Terumo
Others include: Abbott, AgaMatrix, Artsana, Apollo, BBI Healthcare, B. Braun, Berger, Beurer, Boehringer Ingelheim, Cellnovo, Codan, Comfort Point, Dario Health, Elektronika, Entra Health Systems, GlucoRx, GlucoZen, Infopia, Medtronic, MED TRUST, Medisana, Menarini, Merck Serono, MSP bodmann, Neon Diagnostics, NordicInfu Care, Novalab Ibérica, Novico, Owen Mumford, Pentaferte, Roche, Sanofi, SD BIOSENSOR, SFM Medical, Smiths Medical, Spirit Healthcare, Sooil, Trividia Health, Ypsomed, etc.
